Physicians' Academy for Cardiovascular Education

Shared decision-making with lifetime risk model

10' education - Nov. 5, 2018 - Dr. Jannick Dorresteijn - Utrecht, The Netherlands

Video navigation menu

  • Novelty of the SMART-REACH model 1:21
  • Prediction of treatment effects based on observational data 2:20
  • Use of model in clinical practice 3:17
  • Whom is the model useful for? 4:27
  • Potential advantages of U-prevent 5:10

Educational information

In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from perspective of young investigators. They put a question to researchers about presented study results.


Dr. Jannick Dorresteijn - Fellow of Vascular Medicine, University Medical Center of Utrecht, The Netherlands


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Read more about U-prevent

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: